Charles River Laboratories Announces Third-Quarter 2015 Results from Continuing Operations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Charles River Laboratories (CRL) Tops Q3 EPS by 9c; Guides Above the Street
November 4, 2015 7:06 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.03, $0.09 better than the analyst estimate of $0.94. Revenue for the quarter came in at $349.5 million versus the consensus estimate of $340.09 million.
Charles River Laboratorie sees FY2015 EPS of $3.69-$3.74, versus the consensus of $3.64.
James C. Foster, Chairman,... More
